A detailed history of American Capital Management Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, American Capital Management Inc holds 147,800 shares of CRL stock, worth $27.7 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares
147,800
Previous 183,300 19.37%
Holding current value
$27.7 Million
Previous $37.9 Million 23.11%
% of portfolio
0.96%
Previous 1.27%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$187.96 - $245.29 $6.67 Million - $8.71 Million
-35,500 Reduced 19.37%
147,800 $29.1 Million
Q4 2023

Feb 14, 2024

BUY
$164.52 - $238.84 $49,356 - $71,652
300 Added 0.16%
183,300 $43.3 Million
Q2 2023

Aug 14, 2023

BUY
$183.71 - $210.25 $1.47 Million - $1.68 Million
8,000 Added 4.57%
183,000 $38.5 Million
Q1 2023

May 03, 2023

BUY
$191.89 - $259.92 $1.15 Million - $1.56 Million
6,000 Added 3.55%
175,000 $35.3 Million
Q4 2022

Feb 14, 2023

SELL
$197.11 - $250.07 $197,110 - $250,070
-1,000 Reduced 0.59%
169,000 $36.8 Million
Q1 2022

May 16, 2022

SELL
$255.51 - $362.11 $127,755 - $181,055
-500 Reduced 0.29%
170,000 $48.3 Million
Q3 2021

Nov 15, 2021

SELL
$372.64 - $458.3 $1.86 Million - $2.29 Million
-5,000 Reduced 2.85%
170,500 $70.4 Million
Q3 2020

Nov 16, 2020

SELL
$175.56 - $226.45 $2.63 Million - $3.4 Million
-15,000 Reduced 7.87%
175,500 $39.7 Million
Q4 2019

Feb 12, 2020

BUY
$126.05 - $152.76 $1.83 Million - $2.22 Million
14,550 Added 8.27%
190,500 $29.1 Million
Q4 2017

Jan 23, 2018

BUY
$100.43 - $118.09 $2.82 Million - $3.31 Million
28,050 Added 18.97%
175,950 $19.3 Million
Q1 2017

Apr 18, 2018

BUY
N/A
147,900
147,900 $13.3 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.54B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track American Capital Management Inc Portfolio

Follow American Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Capital Management Inc with notifications on news.